The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...